Swedish Orphan Biovitrum Dividend yield

 Price  236.70
 Dividend  0.00
 Earnings  17.40
 Cash-flow  17.66
 Book value  67.63
 Equity  63.04

Swedish Orphan Biovitrum is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Swedish Orphan Biovitrum is a company from Sweden, and his stocks are publicly traded.

Swedish Orphan Biovitrum paid a total dividend of 0 million SEK last year, for a market value of 69,827 millions (Market Cap 41,707 millions). Dividend per share of Swedish Orphan Biovitrum is 0.00 SEK, and his stock market price 236.70 SEK.

According to the chart below where dividend yield is displayed, Swedish Orphan Biovitrum, has a dividend yield of 0%, amount in contrast with the positive dividend offered by both the market average and companies from Sweden, Health Care industry, and Pharmaceuticals and Biotechnology sector. This lack of dividends of Swedish Orphan Biovitrum might harm the evolution of share price if the company is not clearly expanding his business.

In addition, you should compare Swedish Orphan Biovitrum dividend yield with other Pharmaceuticals and Biotechnology companies or firms from Sweden.

Dividend yield of Swedish Orphan Biovitrum

Swedish Orphan Biovitrum Dividend Payout

About the ability of Swedish Orphan Biovitrum to maintain his current dividend of SEK 0.00 per share, an amount that accounts for 0.00%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Swedish Orphan Biovitrum payout on ernings is currently 0.00%, which is lower than the market average and companies in his industry and sector.

The following figure shows payout ratios over earnings and cashflow of Swedish Orphan Biovitrum, compared againt world market average, Sweden companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Swedish Orphan Biovitrum payout

Swedish Orphan Biovitrum Dividend History

Year Yield  SEK  Paypout  Shares* 

*In millions

Swedish Orphan Biovitrum Stock performance

Finally, last moth Swedish Orphan Biovitrum showed a return of 25.90% compared to a worldwide -1.33% average, and a -3.33% of Health Care firms. Over the last year, the company obtained a 9.20% versus a worldwide performance of a 31.58%. More detailed information can be seen in the following graph for Sweden and Pharmaceuticals and Biotechnology firms.

Swedish Orphan Biovitrum stock and market return